MYCAMINE

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug MYCAMINE contains one active pharmaceutical ingredient (API):

1	Micafungin UNII IS1UP79R56 - MICAFUNGIN SODIUM
	Micafungin non-competitively inhibits the synthesis of 1,3-β-D-glucan, an essential component of the fungal cell wall. 1,3-β-D-glucan is not present in mammalian cells. Micafungin exhibits fungicidal activity against most Candida species and prominently inhibits actively growing hyphae of Aspergillus species.
	Read more about Micafungin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MYCAMINE Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J02AX05	Micafungin	J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AX Other antimycotics for systemic use
Discover more medicines within J02AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	540300102152212, 540300104155219
CA	Health Products and Food Branch	02294222, 02311054
EE	Ravimiamet	1381610, 1381621
ES	Centro de información online de medicamentos de la AEMPS	08448001, 08448002
FI	Lääkealan turvallisuus- ja kehittämiskeskus	158608, 158619
FR	Base de données publique des médicaments	62450342, 63197760
GB	Medicines & Healthcare Products Regulatory Agency	137867, 137990
HK	Department of Health Drug Office	55160
IL	מִשְׂרַד הַבְּרִיאוּת	7827, 7828
IT	Agenzia del Farmaco	038705012, 038705024
LT	Valstybinė vaistų kontrolės tarnyba	1032175, 1032176
NL	Z-Index G-Standaard, PRK	91855, 91863
NZ	Medicines and Medical Devices Safety Authority	16204, 16205
PL	Rejestru Produktów Leczniczych	100187432, 100187580
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W53472001, W53473001
SG	Health Sciences Authority	14464P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699043890307, 8699043890314
US	FDA, National Drug Code	0469-3211, 0469-3250
ZA	Health Products Regulatory Authority	44/20.2.2/0639, 44/20.2.2/0640